The demand for lab testing devices in India continues to grow as pathology labs are upgrading their facilities. This category of medical devices includes:
- Microbiology, hematology and In Vitro Diagnostic (IVD) devices such as blood glucose meters, hematology analyzers, blood gas analyzer, blood bank refrigerators and specimen receptacles
- Immunology, oncology and allergy devices such as linear accelerators and immunoassays analyzers
- Pathology devices such as tissue microarrays and microscopes
- Reagents and consumables
- Labware such as petri dishes, pipettes and burettes.
India has over 100,000 medical diagnostic facilities, of which approximately 70,000 offer dedicated pathology services. The remaining facilities primarily provide radiology and imaging services, such as MRI, CT scans, X-rays, and ultrasound. Although the market remains fragmented, with roughly 70% of providers operating as independent, single- or dual-location small businesses, large organized diagnostic chains are expanding rapidly.
For example, domestic diagnostic leader Dr. Lal PathLabs now operates nearly 300 clinical laboratories and a network exceeding 18,000 patient service centers and pick-up points nationwide. Other major pan-India chains include Agilus Diagnostics (formerly SRL Diagnostics), Metropolis Healthcare (which acquired US-based Quest Diagnostics’ Indian clinical lab operations in 2018), and Thyrocare.
Many labs are located surrounding major hospitals in urban areas. Revenues in this category have grown at double digit rates due to the increasing demand for healthcare, increases in price and dependence on tests by clinicians. There are top tier, large, automated labs which are certified by India’s National Accreditation Board for Testing and Calibration Laboratories (NABL), while at the same time, there are thousands of uncertified labs, some of which are looking to convert from manual processes to various degrees of automation.
The Indian In Vitro Diagnostics (IVD) market is estimated at approximately $1.8 billion to $2.2 billion, while the broader clinical diagnostic laboratory services market exceeds $10 billion. Foreign multinational corporations continue to hold significant market share, led by Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, bioMérieux, Danaher (Beckman Coulter), and QuidelOrtho (formerly Johnson & Johnson’s Ortho Clinical Diagnostics). Domestic manufacturing is also surging under government “Make in India” initiatives; key players include Transasia Bio-Medicals (India’s largest domestic IVD manufacturer) and Goa-based Tulip Diagnostics (acquired by global diagnostic leader Revvity, formerly PerkinElmer). Additionally, India maintains an active market for refurbished and certified pre-owned diagnostic and imaging equipment imported from Western countries.
Last updated: August 3rd, 2026
